Exclusion Criteria
- Taking anticoagulant medication for concomitant medical condition (unless can be safely discontinued for cryoablation procedure)
- Prior allogeneic bone marrow/stem cell or solid organ transplant
- Chronic use (> 2 weeks) of greater than physiologic doses of a corticosteroid agent (dose equivalent to > 10 mg/day of prednisone) within 30 days of the first day of study drug treatment
- Topical and inhaled corticosteroids are permitted
- Concomitant autoimmune disease (e.g., rheumatoid arthritis, multiple sclerosis, autoimmune thyroid disease, uveitis)
- Prior experimental cancer vaccine treatment (e.g., dendritic cell therapy, heat shock vaccine)
- Immunosuppressive therapy, including: cyclosporine, antithymocyte globulin, or tacrolimus within 3 months of study entry
- History of blood transfusion reactions
- Known allergy to bovine products
- Know allergy to murine products
- Progressive viral or bacterial infection
- All infections must be resolved and the patient must remain afebrile for seven days without antibiotics prior to being placed on study
- Cardiac disease of symptomatic nature or cardiac ejection fraction < 45%
- Symptomatic pulmonary disease or FEV1, FVC, and DLCO ≤ 50% predicted
- History of HIV positivity or AIDS
- HBV and/or HCV positivity is permitted
Clinical Trial of an Experimental
Cancer Vaccine
- Personalized experimental anti cancer vaccine
- Combines tumor cryoablation with AlloStim™
Have Questions?
Chat Now
Specialist Available